Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Bidlingmaier

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Cancer Research|February 18, 2009
Identification of MCAM/CD146 as the target antigen of a human monoclonal antibody that recognizes both epithelioid and sarcomatoid types of mesotheliomaScott Bidlingmaier, Jiang He, Yong Wang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 18, 2023
Evaluation of <sup>134</sup>Ce/<sup>134</sup>La as a PET Imaging Theranostic Pair for <sup>225</sup>Ac α-RadiotherapeuticsKondapa Naidu Bobba, Anil P Bidkar, Niranjan Meher, et al.
JCI Insight|September 7, 2018
Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancerYang Su, Yue Liu, Christopher R Behrens, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 11, 2023
CD46 targeted <sup>212</sup>Pb alpha particle radioimmunotherapy for prostate cancer treatmentJun Li, Tao Huang, Jun Hua, et al.
Theranostics|February 23, 2024
Development of CD46 targeted alpha theranostics in prostate cancer using <sup>134</sup>Ce/<sup>225</sup>Ac-Macropa-PEG<sub>4</sub>-YS5Kondapa Naidu Bobba, Anil P Bidkar, Anju Wadhwa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2026
Synergistic treatment of prostate cancer and multiple myeloma using CD46-targeted radioimmunotherapy-antibody drug conjugatesAnil P Bidkar, Scott Bidlingmaier, Anju Wadhwa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2025
Effective Treatment of Disseminated Prostate Cancer Using CD46-Targeted 225Ac TherapyAnil P Bidkar, Robin Peter, Anju Wadhwa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2023
CD46-Targeted Theranostics for PET and 225Ac-Radiopharmaceutical Therapy of Multiple MyelomaAnju Wadhwa, Sinan Wang, Bonell Patiño-Escobar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 14, 2023
Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle RadioimmunotherapyAnil P Bidkar, Sinan Wang, Kondapa Naidu Bobba, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Cancer Research|February 18, 2009
Identification of MCAM/CD146 as the target antigen of a human monoclonal antibody that recognizes both epithelioid and sarcomatoid types of mesotheliomaScott Bidlingmaier, Jiang He, Yong Wang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 18, 2023
Evaluation of <sup>134</sup>Ce/<sup>134</sup>La as a PET Imaging Theranostic Pair for <sup>225</sup>Ac α-RadiotherapeuticsKondapa Naidu Bobba, Anil P Bidkar, Niranjan Meher, et al.
JCI Insight|September 7, 2018
Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancerYang Su, Yue Liu, Christopher R Behrens, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 11, 2023
CD46 targeted <sup>212</sup>Pb alpha particle radioimmunotherapy for prostate cancer treatmentJun Li, Tao Huang, Jun Hua, et al.
Theranostics|February 23, 2024
Development of CD46 targeted alpha theranostics in prostate cancer using <sup>134</sup>Ce/<sup>225</sup>Ac-Macropa-PEG<sub>4</sub>-YS5Kondapa Naidu Bobba, Anil P Bidkar, Anju Wadhwa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2026
Synergistic treatment of prostate cancer and multiple myeloma using CD46-targeted radioimmunotherapy-antibody drug conjugatesAnil P Bidkar, Scott Bidlingmaier, Anju Wadhwa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2025
Effective Treatment of Disseminated Prostate Cancer Using CD46-Targeted 225Ac TherapyAnil P Bidkar, Robin Peter, Anju Wadhwa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2023
CD46-Targeted Theranostics for PET and 225Ac-Radiopharmaceutical Therapy of Multiple MyelomaAnju Wadhwa, Sinan Wang, Bonell Patiño-Escobar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 14, 2023
Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle RadioimmunotherapyAnil P Bidkar, Sinan Wang, Kondapa Naidu Bobba, et al.
Pageof 3